<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/antx" ></link>
<id>urn:uuid:6415307d-8003-9722-8194-d0130702f5bf</id>
<updated>2026-09-15T23:51:35-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ANTX: READNOUR ROBIN SHANE (DIR) Sold (AS) 1,108 Shares of AN2 THERAPEUTICS INC for $6.02 on 9/9</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6468293" ></link>
<id>urn:uuid:8f608fae-19f7-372e-a54a-3c08d96bd7a5</id>
<updated>2026-09-11T19:45:59-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: READNOUR ROBIN SHANE (DIR) Sold (AS) 16,119 Shares of AN2 THERAPEUTICS INC for $6.02 on 9/3-9/8</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6466421" ></link>
<id>urn:uuid:36899698-478f-761f-a6fc-6dc626221db5</id>
<updated>2026-09-08T19:42:53-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: WILLIAMS SARAH JOANNE (AO) Sold (S) 272 Shares of AN2 THERAPEUTICS INC for $5.53 on 9/1</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6465585" ></link>
<id>urn:uuid:a9a00310-1a46-ac59-9eed-e502a8419607</id>
<updated>2026-09-04T16:25:33-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: FITZPATRICK MARGARET M (DIR) Bought (B) 2,098 Shares of AN2 THERAPEUTICS INC for $5.53 on 9/1</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6463883" ></link>
<id>urn:uuid:02c1f741-3639-3320-d78f-3fb26d14ccdd</id>
<updated>2026-09-02T18:43:59-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: TRENOR CAMERON C III (O) Filed a Form 3, Becoming a Registered Insider at AN2 THERAPEUTICS INC With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6460994" ></link>
<id>urn:uuid:85060aeb-dc49-81e8-c0ec-78f062d40f7d</id>
<updated>2026-08-27T14:15:57-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: READNOUR ROBIN SHANE (DIR) Sold (AS) 35,402 Shares of AN2 THERAPEUTICS INC for $6.01 on 8/17</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6457293" ></link>
<id>urn:uuid:da5d4df1-c009-acba-1337-1d9d8266c78f</id>
<updated>2026-08-19T17:58:27-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: ZAKRZEWSKI JOSEPH S (DIR) Disposed (JS) 405,880 Shares of AN2 THERAPEUTICS INC for $0.00 on 8/14</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6453958" ></link>
<id>urn:uuid:9448bd8e-8703-90c5-9e44-9815f7e90095</id>
<updated>2026-08-14T14:12:12-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: AZIZ KABEER (DIR) Acquired (JB) 2,852 Shares of AN2 THERAPEUTICS INC for $0.00 on 7/10</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6440775" ></link>
<id>urn:uuid:dc32862d-d800-6402-669a-40c4432f2265</id>
<updated>2026-07-10T19:41:32-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: MARKS GILBERT LYNN (DIR) Acquired (JB) 2,789 Shares of AN2 THERAPEUTICS INC for $0.00 on 7/10</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6440776" ></link>
<id>urn:uuid:0c5086e6-ae7a-8bee-340f-8930e5f728be</id>
<updated>2026-07-10T19:41:06-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
<entry>
<title>ANTX: MARTIN PATRICIA A (DIR) Acquired (JB) 766 Shares of AN2 THERAPEUTICS INC for $0.00 on 7/10</title>
<link href="http://www.insiderinsights.com/company/antx/an2-therapeutics-inc/id-6440774" ></link>
<id>urn:uuid:454cca7e-5dcb-7631-90ea-91bf0c6cc901</id>
<updated>2026-07-10T19:40:14-04:00</updated>
<summary type="html" ><![CDATA[AN2 THERAPEUTICS INC (ANTX). Recent Price: $5.41. Mkt Cap:204.2mm. 10D Vol: 204,460]]></summary>
</entry>
</feed>